Test Directory
| Test Code | |||||
| CXBV | |||||
| Test Name | |||||
| Coxsackie B Virus Antibodies | |||||
| CPT Codes | |||||
| 86658 X 6 | |||||
| Included Tests | |||||
|
|||||
| Expected Turnaround Time | |||||
| 2 - 4 days | |||||
| Clinical Utility | |||||
|
This test is used to aid in diagnosing Coxsackie virus infection. Coxsackie B viruses cause a wide variety of illnesses, including pleurodynia (Bornholm disease), meningitis, rash, pulmonary infection and a generalized systemic infection. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain
Desired Specimen Volume: 1 mL
|
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Methodology | |||||
| IFA | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
The results obtained from this assay are not to be used to determine immunity. A negative serological result does not exclude an infection. Particularly in the early phase of an infection, antibodies may not yet be present or are only present in such small quantities that they are not detectable. A positive result indicates that there has been contact with the pathogen. A positive result together with an increase in the antibody titer is considered to be a clear indication of an acute or very recent Coxsackie virus infection. Acute infections can also be diagnosed on the basis of significant antibody titer increase within two weeks. |
|||||
| Alternate Names | |||||
|
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Monday-Friday | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.